Package 72611-716-01

Brand: dexrazoxane

Generic: dexrazoxane for injection
NDC Package

Package Facts

Identity

Package NDC 72611-716-01
Digits Only 7261171601
Product NDC 72611-716
Product ID 72611-716_a3124d19-54cd-331f-5f11-1be2912795aa
Description

1 VIAL, SINGLE-DOSE in 1 CARTON (72611-716-01) / 50 mL in 1 VIAL, SINGLE-DOSE

Marketing

Marketing Status
Marketed Since 2020-09-01
Brand dexrazoxane
Generic dexrazoxane for injection
Sample Package No

Linked Drug Pages (1)

Dexrazoxane ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "a3124d19-54cd-331f-5f11-1be2912795aa", "openfda": {"unii": ["5346058Q7S"], "rxcui": ["1736590"], "spl_set_id": ["e9550d22-6069-a6de-9968-6a18c9e0448f"], "manufacturer_name": ["Almaject, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 VIAL, SINGLE-DOSE in 1 CARTON (72611-716-01)  / 50 mL in 1 VIAL, SINGLE-DOSE", "package_ndc": "72611-716-01", "marketing_start_date": "20200901"}], "brand_name": "Dexrazoxane", "product_id": "72611-716_a3124d19-54cd-331f-5f11-1be2912795aa", "dosage_form": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION", "pharm_class": ["Cytoprotective Agent [EPC]"], "product_ndc": "72611-716", "generic_name": "Dexrazoxane for Injection", "labeler_name": "Almaject, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Dexrazoxane", "active_ingredients": [{"name": "DEXRAZOXANE HYDROCHLORIDE", "strength": "500 mg/50mL"}], "application_number": "ANDA207321", "marketing_category": "ANDA", "marketing_start_date": "20200901", "listing_expiration_date": "20261231"}